Latest Breaking News On - ப்ரிலிமிநரீ கண்டுபிடிப்புகள் - Page 7 : vimarsana.com

Study reports on safety of COVID-19 mRNA vaccines in pregnancy Researchers used different surveillance systems in the United States to track adverse outcomes after coronavirus disease 2019 (COVID-19) vaccination in pregnant people and found no major safety flags. In the United States, mRNA vaccines were the first to receive emergency use authorization to combat COVID-19. However, these vaccines were not approved for use in pregnant women as the clinical trial did not include pregnant women, and there is very little data on the safety of the vaccines among pregnant women. However, pregnant women are more at risk of severe disease compared to the non-pregnant population. There may also be a greater risk of adverse outcomes like preterm birth. Hence, guidelines have been issued that pregnant women should also be given the vaccine. However, these women should be monitored after vaccination to determine safety.

United statesLakshmi supriyaUs centers for disease controlPhd aprPreliminary findingsImage creditNew england journalVaccine adverse event reporting systemDisease controlCoronavirus disease covid 19Ars cov 2Clinical trialஒன்றுபட்டது மாநிலங்களில்லட்சுமி சுப்ரியாஎங்களுக்கு மையங்கள் க்கு நோய் கட்டுப்பாடுஃப்ட் ஏப்ரல்